A published regulatory template sharing best practices for filing RBPS data would benefit the industry and regulatory reviewers by enabling a consistent presentation of predictive data and conclusions.
Hanlin Li
Advertisement
Hanlin Li is associate director at Vertex Pharmaceuticals.
Articles by Hanlin Li
Advertisement
Latest Updated Articles
Risk-Based Predictive Stability for Pharmaceutical Development–A Proposed Regulatory TemplatePublished: August 2nd 2018 | Updated:
Advertisement
Advertisement
